Search results
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
UPDATE 3-GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo Finance· 1 year agoDrugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 1 year agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
GSK, Sanofi shares rise after U.S. judge dismisses Zantac cancer link lawsuits
Investing.com via Yahoo Finance· 1 year agoBy Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) and Sanofi SA (EPA:SASY) soared on Wednesday after the drugmakers saw tens of thousands of lawsuits involving the heartburn medicine ...
UPDATE 1-Judge weighs key evidence ahead of first Zantac cancer trial
Reuters via Yahoo Finance· 1 year agoLawyers for a man who alleges he developed bladder cancer after taking GSK Plc's heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the ...
Wonderbelly is taking on Tums
TechCrunch· 2 years agoDeep tech and D2C have very little in common, except Noah Kraft. The Doppler Labs founder, who first came into the spotlight in 2014 with the launch of a...
